Ki-16425

N/A

Report date: 2021/12/07 16:28:48

Base Information

Drug NameKi-16425
Drug Alias NameKi16425
ClassificationSmall molecules
Mechanisms of ActionLysophosphatidic acid receptor Edg-7 antagonistsLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-7Lysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKirin Brewery Company Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A